Recent Quotes

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; NM-088 for the treatment of glaucoma; and IntegraSyn.

Ticker	Company	Price	Change	Chg %		Mkt Cap
INM	InMed Pharmaceuticals	2.89	0.04	1.4%		23.3M

InMed Pharmaceuticals Frequently Asked Questions

How do I buy InMed Pharmaceuticals (INM) stock?

You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.

View our list of the best stock brokerages.

Who are InMed Pharmaceuticals's (INM) competitors?

There are no as such competitors for InMed Pharmaceuticals.

What is the target price for InMed Pharmaceuticals (INM) stock?

There is no analysis for InMed Pharmaceuticals

Current Stock Price for InMed Pharmaceuticals (INM)?

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $2.89 last updated Mon Jun 14 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does InMed Pharmaceuticals (INM) pay a dividend?

There are no upcoming dividends for InMed Pharmaceuticals.

When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?

InMed Pharmaceuticals does not have any upcoming earnings scheduled.

Is InMed Pharmaceuticals (INM) going to split?

There is no upcoming split for InMed Pharmaceuticals.

What sector and industry does InMed Pharmaceuticals (INM) operate in?

InMed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.